On the benefits of screening - Hepatocellular cancer complicating hepatitis C
Vol. 7 No. 1 (2014), Case Report
Vol. 7 No. 1 (2014)

On the benefits of screening - Hepatocellular cancer complicating hepatitis C

Case Report
https://doi.org/10.48037/mbmj.v7i1.192
Published 2014-04-01
  • Olajumoke Adeloye
Olajumoke Adeloye
pdf

Keywords

Hepatocellular cancer
Hepatitus C
Liver

Abstract

 

 

 

https://doi.org/10.48037/mbmj.v7i1.192
pdf

References

Booth JCL, O’Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C. Royal College of Physicians of London and the British Society of Gastroenterology. 2001. Volume 49 Supplement I

National Institute for Health and Care Excellence. Boceprevir for the treatment of genotype 1 chronic hepatitis C. NICE TA253. April 2012

National Institute for Health and Care Excellence. Telaprevir for the treatment of genotype 1 chronic hepatitis C. NICE TA252. April 2012

Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52(Suppl III):iii1-iii8. Available from: https://doi.org/10.1136/gut.52.suppl_3.iii1